Download PDF
Thromb Haemost 1982; 47(03): 294
DOI: 10.1055/s-0038-1657189
Letter to the Editor
Schattauer GmbH Stuttgart

Thromboxane Synthetase Inhibition Results in Increased Platelet Sensitivity to Prostacyclin

Vittorio Bertelé
Istituto di Ricerche Farmacologiche, «Mario Negriu», Via Eritrea, 62, 20157 Milan, Italy
,
Anna Falanga
Istituto di Ricerche Farmacologiche, «Mario Negriu», Via Eritrea, 62, 20157 Milan, Italy
,
Maria Carla Roncaglioni
Istituto di Ricerche Farmacologiche, «Mario Negriu», Via Eritrea, 62, 20157 Milan, Italy
,
Chiara Cerletti
Istituto di Ricerche Farmacologiche, «Mario Negriu», Via Eritrea, 62, 20157 Milan, Italy
,
Giovanni de Gaetano
Istituto di Ricerche Farmacologiche, «Mario Negriu», Via Eritrea, 62, 20157 Milan, Italy
› Author Affiliations
Further Information

Publication History

Received 22 February 1982

Accepted 12 March 1982

Publication Date:
13 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Bertelé V, Cerletti C, Schieppati A, Di Minno G, de Gaetano G. Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet 1981; 1: 1057-1058
    PubMedGoogle Scholar
  • 2 Bills TK, Smith JB, Silver MJ. Metabolism of [14C] arachidonic acid by human platelets. Biochim Biophys Acta 1976; 424: 303-314
    CrossrefPubMedGoogle Scholar
  • 3 Miller OV, Gorman RR. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets. J Pharmacol Exp Ther 1979; 210: 134-140
    PubMedGoogle Scholar
  • 4 de Gaetano G. Prostaglandin effects on platelets In: Abstracts, Prostaglandins in Cardiovascular and Thrombotic Disorders, Proc Symp Chicago. Illinois, May 7–9, 1981
    PubMedGoogle Scholar